Deva Holding AS | DEVA - 资产



金融业
股票价格
TRY
资产
TRY 12.93B
现金及等价物
TRY 775.92M
销售成本
TRY 991.13M
流动资产
TRY 9.13B
流动负债
TRY 6.43B
债务
TRY 5.3B
股息收益率
0.18
EBIT
TRY 820.88M
EBITDA
TRY 882.9M
EPS每股收益
TRY 2.92
股本和储备
TRY 5.79B
销售毛利
TRY 1.32B
债务利息支出
TRY 272.53M
贷款资金
TRY 559.97M
市值
TRY 17.83B
净收入
TRY 583.98M
营业费用
TRY 1.35B
营业利润
TRY 964.87M
普通股股本
TRY 200.02M
PE价格收益
6.55
销售收入
TRY 2.32B
销售和管理费用
TRY 462.26M
贸易债权人
TRY 809.81M
应收帐款人
TRY 3.03B


资产 更改 日
Akebia Therapeutics USD 349.66M 12.86M 2026-06
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Avita Medical AUD 56.39M 1.74M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Moderna USD 10.96B 527M 2026-06
Organon & Co USD 13.18B 182M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Viatris USD 35.04B 1.79B 2026-06
Xeris Pharmaceuticals USD 411.9M 19.89M 2026-06